Literature DB >> 26460806

Age of onset of recurrent respiratory papillomatosis: a distribution analysis.

M R M San Giorgi1,2, E R van den Heuvel3, R E A Tjon Pian Gi1,2, J W Brunings4, M Chirila5, G Friedrich6, W Golusinski7, M Graupp6, R A Horcasitas Pous8, T Ilmarinen9, J Jackowska10, J C Koelmel11, F Ferran Vilà12, V Weichbold13, M Wierzbicka10, F G Dikkers14,15.   

Abstract

OBJECTIVE: Distribution of age of onset of recurrent respiratory papillomatosis (RRP) is generally described to be bimodal, with peaks at approximately 5 years and 30 years. This assumption has never been scientifically confirmed, and authors tend to refer to an article that does not describe distribution. Knowledge of the distribution of age of onset is important for virological and epidemiological comprehension. The objective of this study was to determine the distribution of age of onset of RRP in a large international sample.
DESIGN: Cross-sectional distribution analysis. PARTICIPANTS: Laryngologists from 12 European hospitals provided information on date of birth and date of onset of all their RRP patients treated between 1998 and 2012. Centers that exclusively treated either patients with juvenile onset RRP or patients with adult onset RRP, or were less accessible for one of these groups, were excluded to prevent skewness. MAIN OUTCOME MEASURES: A mixture model was implemented to describe distribution of age of onset. The best fitting model was selected using the Bayesian information criterion.
RESULTS: Six hundred and thirty-nine patients were included in the analysis. Age of onset was described by a three component mixture distribution with lognormally distributed components. Recurrent respiratory papillomatosis starts at three median ages 7, 35 and 64 years.
CONCLUSIONS: Distribution of age of onset of RRP shows three peaks. In addition to the already adopted idea of age peaks at paediatric and adult age, there is an additional peak around the age of 64.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 26460806     DOI: 10.1111/coa.12565

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  7 in total

Review 1.  Strengthening the case for gender-neutral and the nonavalent HPV vaccine.

Authors:  Justin M Hintze; James P O'Neill
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-01-11       Impact factor: 2.503

Review 2.  A review of the risk factors associated with juvenile-onset recurrent respiratory papillomatosis: genetic, immune and clinical aspects.

Authors:  Shi-Lan Li; Wei Wang; Jing Zhao; Feng-Zhen Zhang; Jie Zhang; Xin Ni
Journal:  World J Pediatr       Date:  2022-01-24       Impact factor: 2.764

Review 3.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

4.  Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis.

Authors:  Farrel J Buchinsky; William L Valentino; Nicole Ruszkay; Evan Powell; Craig S Derkay; Riaz Y Seedat; Virgilijus Uloza; Frederik G Dikkers; David E Tunkel; Sukgi S Choi; Anthony J Mortelliti; Paolo Campisi; Juan C Ospina; Adam J Donne; Robert T Sataloff; Stephen F Conley; John E McClay; Ellen M Friedman; Lisa Elden; Dale A Tylor; Clark A Rosen; Libby J Smith; Graeme J Copley; David E Karas; John M Schweinfurth; Charles M Myer; Brian J Wiatrak; Joseph E Dohar; Steven E Sobol; Robert W Bastian; Richard J H Smith; Marshall E Smith; Abebe M Wassie; James C Post; Garth D Ehrlich
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

Review 5.  Comparing KTP and CO2 laser excision for recurrent respiratory papillomatosis: A systematic review.

Authors:  Jimin Yang; Zhongcheng Xie; Barnabas C Seyler
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-07-16

Review 6.  Virus-Associated Biomarkers in Oropharyngeal and Nasopharyngeal Cancers and Recurrent Respiratory Papillomatosis.

Authors:  Shigeyuki Murono
Journal:  Microorganisms       Date:  2021-05-27

Review 7.  Juvenile-Onset Recurrent Respiratory Papillomatosis Diagnosis and Management - A Developing Country Review.

Authors:  R Y Seedat
Journal:  Pediatric Health Med Ther       Date:  2020-02-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.